Large brain analysis finds dementia risk tied to advanced stages of the disease. The National Institutes of Health (NIH) recently reported the findings of a federally funded study…
Read MoreNeuroscience
FDA Approves New Schizophrenia Treatment with a Breakthrough Mechanism
Cobenfy offers an alternative that addresses symptoms of schizophrenia with a different approach. The U.S. Food and Drug Administration (FDA) recently approved Cobenfy (xanomeline and trospium chloride) for…
Read More